Cargando…
A real-world assessment of tolerability and treatment outcomes of COVID-19 monoclonal antibodies administered in pregnancy
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780055/ https://www.ncbi.nlm.nih.gov/pubmed/35074337 http://dx.doi.org/10.1016/j.ajog.2022.01.018 |
| _version_ | 1784637736314994688 |
|---|---|
| author | Chang, Mei H. Cowman, Kelsie Guo, Yi Bao, Hongkai Bernstein, Peter S. Gendlina, Inessa Nori, Priya |
| author_facet | Chang, Mei H. Cowman, Kelsie Guo, Yi Bao, Hongkai Bernstein, Peter S. Gendlina, Inessa Nori, Priya |
| author_sort | Chang, Mei H. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8780055 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-87800552022-01-24 A real-world assessment of tolerability and treatment outcomes of COVID-19 monoclonal antibodies administered in pregnancy Chang, Mei H. Cowman, Kelsie Guo, Yi Bao, Hongkai Bernstein, Peter S. Gendlina, Inessa Nori, Priya Am J Obstet Gynecol Research Letter Elsevier Inc. 2022-05 2022-01-21 /pmc/articles/PMC8780055/ /pubmed/35074337 http://dx.doi.org/10.1016/j.ajog.2022.01.018 Text en © 2022 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Research Letter Chang, Mei H. Cowman, Kelsie Guo, Yi Bao, Hongkai Bernstein, Peter S. Gendlina, Inessa Nori, Priya A real-world assessment of tolerability and treatment outcomes of COVID-19 monoclonal antibodies administered in pregnancy |
| title | A real-world assessment of tolerability and treatment outcomes of COVID-19 monoclonal antibodies administered in pregnancy |
| title_full | A real-world assessment of tolerability and treatment outcomes of COVID-19 monoclonal antibodies administered in pregnancy |
| title_fullStr | A real-world assessment of tolerability and treatment outcomes of COVID-19 monoclonal antibodies administered in pregnancy |
| title_full_unstemmed | A real-world assessment of tolerability and treatment outcomes of COVID-19 monoclonal antibodies administered in pregnancy |
| title_short | A real-world assessment of tolerability and treatment outcomes of COVID-19 monoclonal antibodies administered in pregnancy |
| title_sort | real-world assessment of tolerability and treatment outcomes of covid-19 monoclonal antibodies administered in pregnancy |
| topic | Research Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780055/ https://www.ncbi.nlm.nih.gov/pubmed/35074337 http://dx.doi.org/10.1016/j.ajog.2022.01.018 |
| work_keys_str_mv | AT changmeih arealworldassessmentoftolerabilityandtreatmentoutcomesofcovid19monoclonalantibodiesadministeredinpregnancy AT cowmankelsie arealworldassessmentoftolerabilityandtreatmentoutcomesofcovid19monoclonalantibodiesadministeredinpregnancy AT guoyi arealworldassessmentoftolerabilityandtreatmentoutcomesofcovid19monoclonalantibodiesadministeredinpregnancy AT baohongkai arealworldassessmentoftolerabilityandtreatmentoutcomesofcovid19monoclonalantibodiesadministeredinpregnancy AT bernsteinpeters arealworldassessmentoftolerabilityandtreatmentoutcomesofcovid19monoclonalantibodiesadministeredinpregnancy AT gendlinainessa arealworldassessmentoftolerabilityandtreatmentoutcomesofcovid19monoclonalantibodiesadministeredinpregnancy AT noripriya arealworldassessmentoftolerabilityandtreatmentoutcomesofcovid19monoclonalantibodiesadministeredinpregnancy AT changmeih realworldassessmentoftolerabilityandtreatmentoutcomesofcovid19monoclonalantibodiesadministeredinpregnancy AT cowmankelsie realworldassessmentoftolerabilityandtreatmentoutcomesofcovid19monoclonalantibodiesadministeredinpregnancy AT guoyi realworldassessmentoftolerabilityandtreatmentoutcomesofcovid19monoclonalantibodiesadministeredinpregnancy AT baohongkai realworldassessmentoftolerabilityandtreatmentoutcomesofcovid19monoclonalantibodiesadministeredinpregnancy AT bernsteinpeters realworldassessmentoftolerabilityandtreatmentoutcomesofcovid19monoclonalantibodiesadministeredinpregnancy AT gendlinainessa realworldassessmentoftolerabilityandtreatmentoutcomesofcovid19monoclonalantibodiesadministeredinpregnancy AT noripriya realworldassessmentoftolerabilityandtreatmentoutcomesofcovid19monoclonalantibodiesadministeredinpregnancy |